Zuiverheidsrapport per Batch Geverifieerd door Janoshik Huidige Batch: In afwachting van eerste zending Elke batch BPC-157 Oraal die door Pepspan wordt verkocht, wordt onafhankelijk getest door Janoshik Analytical (Praag, Tsjechische Republiek)
This approach delivers the peptide directly into the joint space, concentrating its effects at the site of cartilage damage, synovial inflammation, or tendon injury within the joint, rather than relying on systemic diffusion from a subcutaneous injection site
AOD-9604 is classified as a compound and is not yet FDA-approved for human use or treatment of any medical condition
DSIP Research Overview Linked with sleep-regulating pathways, DSIP is widely examined for its role in promoting deeper and more restorative sleep cycles
Fletcher MM, Belousoff MJ, Harikumar KG, et al
BPC-157 is an investigational synthetic peptide that has not been approved by the FDA for any use